Literature DB >> 10348537

Immediate and late outcomes of subclavian artery stenting.

N Al-Mubarak1, M W Liu, L S Dean, K Al-Shaibi, H D Chastain, S S Lyer, G S Roubin.   

Abstract

Stenting for subclavian artery occlusive disease is being increasingly utilized. To determine the immediate and late outcome of subclavian artery stenting, we studied 38 consecutive patients in whom the procedure was attempted. Technical and clinical success was achieved in 35 patients without complications. Failures occurred only in completely occluded arteries. Late clinical success was demonstrated in 31 patients. Three patients had recurrent symptoms. Two had angiographic restenosis within 4 months of the procedure; both were successfully redilated. The third patient had a new lesion, which was successfully stented. One patient died from lung cancer 10 months after the procedure. We conclude that stenting for subclavian artery occlusive disease has favorable immediate and late clinical outcomes and may be considered as a primary therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10348537     DOI: 10.1002/(SICI)1522-726X(199902)46:2<169::AID-CCD11>3.0.CO;2-4

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Extracranial Revascularization Therapy: Angioplasty and Stenting.

Authors:  Alexander V. Khaw; H. Christian Schumacher; Philip M. Meyers; Rishi Gupta; Randall T. Higashida
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

2.  Adjuvant spinal cord stimulation improves wound healing of peripheral tissue loss due to steal syndrome of the hand: clinical challenge treating a difficult case.

Authors:  Giovanni De Caridi; Mafalda Massara; Filippo Benedetto; Paolo Tripodi; Francesco Spinelli; Antonio David; Raffaele Grande; Lucia Butrico; Raffaele Serra; Stefano de Franciscis
Journal:  Int Wound J       Date:  2014-02-17       Impact factor: 3.315

3.  Percutaneous Transluminal Angioplasty of Subclavian Artery Lesions.

Authors:  Elmir Jahic; Harun Avdagic; Ivana Iveljic; Alisa Krdzalic
Journal:  Med Arch       Date:  2019-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.